Invention Grant
- Patent Title: Human herpesvirus trimeric glycoprotein B, protein complexes comprising trimeric gB and their use as vaccines
-
Application No.: US15103427Application Date: 2014-12-11
-
Publication No.: US09907844B2Publication Date: 2018-03-06
- Inventor: Xinle Cui , Clifford M. Snapper , James J. Mond
- Applicant: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Applicant Address: US MD Bethesda
- Assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Current Assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Current Assignee Address: US MD Bethesda
- Agency: MH2 Technology Law Group, LLP
- International Application: PCT/US2014/069856 WO 20141211
- International Announcement: WO2015/089340 WO 20150618
- Main IPC: A61K39/245
- IPC: A61K39/245 ; C12N7/00 ; C07K7/08 ; C07K14/005 ; A61K39/12 ; A61K39/00

Abstract:
The present disclosure provides modified human herpesvirus glycoprotein B (gB) proteins that incorporate unique mechanisms for generating proteins that mimic their native conformation to enhance their immunogenicity. The modified herpesvirus gB proteins insert a peptide linker at the furin cleavage site in the extracellular domain of herpesvirus gB. When expressed, the gB subunit associates in triplicate to produce a homotrimeric complex, mimicking the native conformation of the gB protein. Also provided are protein complexes comprising a homotrimeric complex of a modified herpesvirus gB protein and herpesvirus gH and gL proteins. Also provided are nucleic acids encoding the modified herpesvirus gB proteins, methods of inducing or suppressing an immune response in a subject by administering a vaccine comprising the modified herpesvirus gB protein, or nucleic acid encoding the same, or a protein complex comprising a homotrimeric complex of the modified herpesvirus gB protein and herpesvirus gH and gL proteins.
Public/Granted literature
Information query